Synonym
iBETBD2; iBETBD-2; iBETBD 2
IUPAC/Chemical Name
4-acetamido-3-fluoro-N-((1r,4S)-4-hydroxycyclohexyl)-5-((S)-1-phenylethoxy)benzamide
InChi Key
FRBRZGLUFOZRGD-JVPBZIDWSA-N
InChi Code
InChI=1S/C23H27FN2O4/c1-14(16-6-4-3-5-7-16)30-21-13-17(12-20(24)22(21)25-15(2)27)23(29)26-18-8-10-19(28)11-9-18/h3-7,12-14,18-19,28H,8-11H2,1-2H3,(H,25,27)(H,26,29)/t14-,18-,19-/m0/s1
SMILES Code
O[C@@H]1CC[C@@H](NC(C2=CC(O[C@@H](C)C3=CC=CC=C3)=C(NC(C)=O)C(F)=C2)=O)CC1
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
414.48
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Liu CS, Rioja I, Bakr A, Veldwijk MR, Sperk E, Herskind C, Weichenhan D,
Prinjha RK, Plass C, Schmezer P, Popanda O. Selective inhibitors of bromodomain
BD1 and BD2 of BET proteins modulate radiation-induced profibrotic fibroblast
responses. Int J Cancer. 2022 Jul 15;151(2):275-286. doi: 10.1002/ijc.33989.
Epub 2022 Mar 15. PMID: 35239184.
2: Preston A, Atkinson S, Bamborough P, Chung CW, Craggs PD, Gordon L, Grandi P,
Gray JRJ, Jones EJ, Lindon M, Michon AM, Mitchell DJ, Prinjha RK, Rianjongdee F,
Rioja I, Seal J, Taylor S, Wall I, Watson RJ, Woolven J, Demont EH. Design and
Synthesis of a Highly Selective and In Vivo-Capable Inhibitor of the
Second Bromodomain of the Bromodomain and Extra Terminal Domain Family of
Proteins. J Med Chem. 2020 Sep 10;63(17):9070-9092. doi:
10.1021/acs.jmedchem.0c00605. Epub 2020 Aug 20. PMID: 32691591.